LEXARIA BIOSCIENCE CORP. (LEXX) Gross margin 2016–2025
LEXARIA BIOSCIENCE CORP. (LEXX) gross margin by fiscal year — reported gross profit divided by reported revenue.
99.6%FY2025 · since FY2016: -12.0% → 99.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 99.6% | +0.7 pp |
| FY2024 | 99.0% | +12.9 pp |
| FY2023 | 86.1% | +14.2 pp |
| FY2022 | 71.9% | -3.9 pp |
| FY2021 | 75.7% | +19.7 pp |
| FY2020 | 56.0% | -33.7 pp |
| FY2019 | 89.7% | -4.5 pp |
| FY2018 | 94.2% | +40.9 pp |
| FY2017 | 53.3% | +65.3 pp |
| FY2016 | -12.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice